Résultats de la recherche - 54 results
Influenza versus other respiratory viruses – assessing severity among hospitalised children, Belgium, 2011 to 2020.
Publication Type: Peer reviewed scientific article Authors: Fischer, Natalie; S Moreels; Dauby, Nicolas; Reynders, Marijke; Petit, Evelyn; Gerard, Michèle; Lacor, Patrick; Daelemans, Siel; Lissoir, Bénédicte; Holemans, Xavier; Magerman, Koen; Jouck, Door; ...
Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.
countries in the European Union/European Economic Area, we estimated XBB.1.5 monovalent vaccine effectiveness (VE) against COVID-19 hospitalisation and death in booster-eligible ≥ 65-year-olds, during ...
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.
against B. During the 2022/2023 season, while VE against hospitalisation with influenza B was >55%, it was ≤20% for influenza A subtypes. While influenza vaccination should be a priority for future ...
Cluster pattern analysis of environmental stressors and quantifying their impact on all-cause mortality in Belgium
leads to a considerable number of diseases, hospitalisations, and excess mortality. Our study encompasses a representative sample size drawn from the Belgian population in 2016 (n = 11.26 million, with ...
Multinational collaboration in solving a European Braenderup outbreak linked to imported melons, 2021.
6 July 2021, Braenderup outbreak cases (n = 348) had been reported from 12 countries in the European Union/European Economic Area (EU / EEA) and the United Kingdom (UK), including 68 hospitalised cases. ...
Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.
COVID-19 Europe Hospitalization Humans Retrospective Studies Vaccine Efficacy Abstract: To monitor relative vaccine effectiveness (rVE) against COVID-19-related hospitalisation of the first, second and third ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021
Publication Type: Peer reviewed scientific article Authors: Rose, Angela MC; Nicolay, Nathalie; Sandonis Martín, Virginia; Mazagatos, Clara; Petrović, Goranka; Niessen, F Annabel; Machado, Ausenda; Launay, Odile; Sarah Denayer; Seyler, Lucie; Baruch, Joaq ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022
Publication Type: Peer reviewed scientific article Authors: Rose, Angela MC; Nicolay, Nathalie; Sandonis Martín, Virginia; Mazagatos, Clara; Petrović, Goranka; Baruch, Joaquin; Sarah Denayer; Seyler, Lucie; Domegan, Lisa; Launay, Odile; Machado, Ausenda; ...
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
Humans REGISTRIES Vaccine Efficacy Abstract: BACKGROUND: Within the ECDC- VEBIS project, we prospectively monitored vaccine effectiveness (VE) against COVID-19 hospitalisation and COVID-19-related death ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
effectiveness (VE) in participating European countries since early 2021.AimWe aimed to measure VE against PCR-confirmed SARS-CoV-2 in patients ≥ 20 years hospitalised with severe acute respiratory infection ...